Advertisement

Topics

Therakos, Inc. Company Profile

00:03 EDT 23rd June 2018 | BioPortfolio

Therakos, Inc., a Johnson & Johnson company, has been a pioneer for more than 20 years in immune cell therapies. Therakos, Inc. markets the only approved integrated systems for extracorporeal photopheresis. For more information, visit www.therakos.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Global and North America Apheresis Equipment Market Status and Future Forecast 20132023 [Report Updated: 24012018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Mallinckrodt LLC Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryMallinckrodt LLC Mallinckrodt, formerly Therakos, Inc., a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis ECP. It offers The...

20152023 World Apheresis Equipment Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 18122017] Prices from USD $2800

SummaryApheresis is an invasive process that involves the separation of components such as platelets, RBC, plasma, and other components from whole blood. In this procedure, the blood of a donor or a p...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Uvadex [Therakos, Inc.]

UVADEX™ (Methoxsalen) STERILE SOLUTION, 20 mcg/mL

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease

This is a single-arm, open-label, multicenter study of the efficacy of UVADEX® (methoxsalen) Sterile Solution in conjunction with THERAKOS® CELLEX® Photopheresis Systems in pediatric pa...

Study of Photopheresis in the Treatment of Erythrodermic MF and SS

PROMPT: a study of photopheresis for the treatment of erythrodermic mycosis fungoides and Sézary syndrome For this study, the investigators invite patients suffering from erythrodermic m...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex

To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).

Companies [1 Associated Companies listed on BioPortfolio]

Therakos, Inc.

Therakos, Inc., a Johnson & Johnson company, has been a pioneer for more than 20 years in immune cell therapies. Therakos, Inc. markets the only approved integrated systems for extracorporeal photophe...

More Information about "Therakos, Inc." on BioPortfolio

We have published hundreds of Therakos, Inc. news stories on BioPortfolio along with dozens of Therakos, Inc. Clinical Trials and PubMed Articles about Therakos, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Therakos, Inc. Companies in our database. You can also find out about relevant Therakos, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record